Meeting
2022 ASCO Annual Meeting
Circulating tumor DNA (ctDNA) in predicting residual disease after neoadjuvant chemoradiotherapy (nCRT) for esophageal squamous cell carcinoma (ESCC).
Authors
Zhichao Liu
Department of Thoracic Surgery, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, China
Zhichao Liu , Yang Yang , Jun Liu , Li Zhu , Hong Yu , Mingjun Zhu , Xi Li , Jie Yang , Jianxing Xiang , Haiyan Li , Bing Li , Zhigang Li
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary
Track
Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary
Sub Track
Esophageal or Gastric Cancer
Clinical Trial Registration Number
NCT03937362
Citation
J Clin Oncol 40, 2022 (suppl 16; abstr 4044)
DOI
10.1200/JCO.2022.40.16_suppl.4044
Abstract #
4044
Poster Bd #
32
Abstract Disclosures
Similar Posters
Poster
2019 ASCO Annual Meeting
Correlation between mutation landscape and clinical outcomes of neoadjuvant therapy in HER2-positive breast cancer patients.
First Author: Ning Liao
Poster
2023 ASCO Genitourinary Cancers Symposium
Association of biomarkers and outcomes in patients (pts) with metastatic urothelial carcinoma (mUC) treated with immune checkpoint inhibitors (ICIs).
First Author: Kevin R Reyes
Poster
2017 ASCO Annual Meeting
Molecular profiling comparison of breast cancer subtypes in young women and older women.
First Author: Antoinette R. Tan
Poster
2022 ASCO Annual Meeting
Molecular alterations associated with rapid progression following CDK4/6 inhibitors (CDKi) in metastatic hormone receptor–positive breast cancer (mHRBC).
First Author: Malinda T West